Peer Review History
| Original SubmissionNovember 26, 2024 |
|---|
|
Dear Dr. Krismanuel, Please submit your revised manuscript by Mar 23 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mukhtiar Baig, Ph.D. Academic Editor PLOS ONE Journal requirements: -->--> -->-->When submitting your revision, we need you to address these additional requirements.-->--> -->-->1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.-->--> -->-->2. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.-->--> -->-->3. Please match your authorship list in your manuscript file and in the system.-->--> -->-->4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. -->--> -->-->Before we proceed with your manuscript, please address the following prompts:-->--> -->-->a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.-->--> -->-->b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.-->--> -->-->Please update your Data Availability statement in the submission form accordingly.-->?> 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: The manuscript presents a community-based educational intervention aimed at improving knowledge and awareness about Prostatic Hyperplasia (PH) among elderly men in Bogor, Indonesia. Overall, the study contributes meaningfully to the field, especially in addressing health education gaps for elderly populations in low-resource settings. Below is the detailed feedback regarding the manuscript: Technical Soundness and Data Support: The manuscript describes a well-structured quasi-experimental study with a pretest-posttest design. The statistical analysis, including paired t-tests and Cohen’s d calculation, is appropriately applied to assess the intervention's effectiveness. The quantitative results are compelling, with a significant increase in knowledge scores post-intervention. Qualitative data enrich the findings by providing deeper insights into participant perceptions. However, the lack of a control group limits the ability to establish causality. Future iterations could consider incorporating control groups to strengthen the validity of the conclusions. Statistical Analysis: The statistical methods employed, including normality tests and effect size calculations, are rigorous and align with the study's objectives. The authors have adequately described the steps taken to ensure the robustness of the analysis. The effect size (Cohen’s d = 0.82) indicates a large practical impact of the intervention, which is encouraging. Data Availability: The data availability statement is adequate, and all relevant data are included within the manuscript and its supporting files. However, it would be beneficial for the authors to specify whether the raw dataset (e.g., anonymized pretest and posttest scores) is available in a public repository for reproducibility. Language and Presentation: The manuscript is written in clear and standard English, making it accessible to a wide audience. The structure of the paper is logical, and the arguments are easy to follow. While there are no major grammatical errors, minor typographical errors should be addressed during revision. Strengths of the Study: The integration of the International Prostatic Symptom Score (I-PSS) into a community education setting is novel and provides a practical tool for participants to self-assess their symptoms. The mixed-methods approach adds depth to the findings by combining quantitative results with qualitative insights. The scalability and low-cost nature of the intervention make it suitable for broader applications in similar settings. Limitations and Suggestions for Improvement: The lack of a control group is a significant limitation. Future studies should aim to include a control group to strengthen causal inferences. The sample size, while adequate for initial findings, could be expanded to improve generalizability. Including family members in the educational sessions may enhance the program’s impact and encourage broader awareness. More interactive elements, such as case studies or role-playing, could further engage participants and reinforce learning. Ethics and Reporting Standards: The study adheres to ethical standards, with appropriate approval obtained and clear documentation of informed consent procedures. The manuscript follows reporting guidelines and includes sufficient methodological details to ensure reproducibility. Conclusion: The study provides strong evidence for the effectiveness of community-based education using the I-PSS tool. It demonstrates potential as a scalable, low-cost intervention to address health education gaps in low-resource settings. The authors have made a valuable contribution to the field of community health education. Reviewer #2: The article is an interesting one but lacks few basic components, like the purpose of study is not clear. The article is about educational intervention and patient education but maximum emphasis is on the statistical details. The pre-test/post-test questionnaire is not provided nor discussed. The results just mention the difference between cumulative score without details of components (like symptoms, management options etc). Statistical details may be reviewed by a stastitician Reviewer #3: The data regarding the education level of participants should be added to this study to identify the relation between the education level and the knowledge of prostate hyperplasia. Therefore, the conclusion should also mention the effectiveness of education level and the impact of health education in the community regarding prostate hyperplasia Reviewer #4: This studies can be applied in daily urology clinical setting. the data used in this research is reliable and has been handled appropriately. The next research about early screening and treatment of benign prostatic hyperplasia can be developed from this studies, by taking larger sampels or populations ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Dr.dr.Reza Aditya Digambiro, M.Kes, M.Ked(PA), Sp.PA Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Examining the effectiveness of prostatic hyperplasia education on the level of participant’s knowledge and awareness PONE-D-24-53996R1 Dear Dr. Krismanuel, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mukhtiar Baig, Ph.D. Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-24-53996R1 PLOS ONE Dear Dr. Krismanuel, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Mukhtiar Baig Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .